Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

1V-LSD

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
1V-LSD
Clinical data
Routes of
administration
oral
Legal status
Legal status
Identifiers
  • (6aR,9R)-N,N-Diethyl-7-methyl-4-pentanoyl-4,,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
PubChemCID
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC25H33N3O2
Molar mass407.558 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@@H]5C=C2[C@@H](Cc3cn(C(=O)CCCC)c4cccc2c34)N(C)C5
  • InChI=1S/C25H33N3O2/c1-5-8-12-23(29)28-16-17-14-22-20(19-10-9-11-21(28)24(17)19)13-18(15-26(22)4)25(30)27(6-2)7-3/h9-11,13,16,18,22H,5-8,12,14-15H2,1-4H3/t18-,22-/m1/s1
  • Key:GIIBVGJWUZNECE-XMSQKQJNSA-N

1V-LSD (1-valeryl-D-lysergic acid diethylamide), sometimes nicknamedValerie, is apsychotropic substance and aresearch chemical withpsychedelic effects.[1][2] 1V-LSD is an artificialderivative of naturallysergic acid, which occurs inergot alkaloids, as well as being ananalogue ofLSD.[3] 1V-LSD has been sold online until an amendment to the GermanNpSG was enforced in 2022 which controls1P-LSD and now1cP-LSD, 1V-LSD and several otherlysergamides.[4]

Pharmacology

[edit]

As demonstrated with other N-acylated derivatives of LSD, 1V-LSD is believed to serve as aprodrug for LSD but may also act as a weakpartial agonist at the5-HT2A receptor.[3]

Animal studies

[edit]

AHead-twitch response assay in mice found that 1V-LSD has a similar potency to 1P-LSD and1cP-LSD, with behavioral effects also closely resembling thesestructural analogs.[5]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Chemistry

[edit]

1V-LSD is the condensation product ofvaleric acid (pentanoic acid) and LSD, where the valeroyl group is substituted on the NH position of theindole moiety.[6]Ehrlich's reagent is used to identify the presence of an indolemoiety; the chemical backbone of the lysergamide andergoline molecules.[7] However, as with other N-acylated lysergamides, 1V-LSD reacts very slowly to Ehrlich reagent and may not give reliable results if the reagent isn't fresh.[8][9]

Legal position

[edit]

1V-LSD is not a controlled substance inNorth America (United States and Canada), unless sold for human consumption in theUS.[10]

Since March 2nd 2022, 1V-LSD has been under investigation in Sweden and may therefore soon become controlled.

1V-LSD was placed under legal control in South Korea in July 2022 on a temporary but renewable basis.[11]

An amendment to the NpSG banned the sale of 1V-LSD in Germany in September 2022. Due to a interpunctation error in the actualised NpSG, the ban never took effect.[12] The law was amended in March 2023, now banning 1V-LSD.

1v-LSD strip blotters

See also

[edit]

References

[edit]
  1. ^"1V-LSD (solution)".www.caymanchem.com.
  2. ^"1V-LSD PsychonautWiki".Psychonautwiki.
  3. ^abBrandt SD, Kavanagh PV, Westphal F, Pulver B, Morton K, Stratford A, et al. (November 2021)."Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD)".Drug Testing and Analysis.14 (4):733–740.doi:10.1002/dta.3205.PMC 9191648.PMID 34837347.
  4. ^"1V-LSD - legales LSD 3.0".YouTube (in German). 10 September 2021.
  5. ^Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, Stratford A, Brandt SD (August 2020)."Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD)".Neuropharmacology.172: 107856.doi:10.1016/j.neuropharm.2019.107856.PMC 9191647.PMID 31756337.
  6. ^Umehara A, Ueda H, Tokuyama H (November 2016). "Condensation of Carboxylic Acids with Non-Nucleophilic N-Heterocycles and Anilides Using Boc2O".The Journal of Organic Chemistry.81 (22):11444–11453.doi:10.1021/acs.joc.6b02097.PMID 27767302.
  7. ^De Faubert Maunder MJ (August 1974). "A field test for hallucinogens: further improvements".The Journal of Pharmacy and Pharmacology.26 (8):637–8.doi:10.1111/j.2042-7158.1974.tb10677.x.PMID 4155730.S2CID 97915487.
  8. ^"REACTIONS 1V-LSD". 16 July 2021.
  9. ^"1V-LSD reaction with the ehrlich reagent". 16 July 2021.
  10. ^21 U.S. Code § 813 - Treatment of controlled substance analogues
  11. ^Kim Chan-hyuk, Regulator names 1V-LSD as narcotic drug temporarily.Korea Biomedical Review, 5 July 2022
  12. ^"Gesetzespanne: Gefährliche LSD-Derivate plötzlich legal".
Psychedelics
(5-HT2A
agonists)
Benzofurans
Lyserg‐
amides
Phenethyl‐
amines
2C-x
25x-NBx
25x-NB
25x-NB3OMe
25x-NB4OMe
25x-NBF
25x-NBMD
25x-NBOH
25x-NBOMe
Atypical structures
25x-NMx
N-(2C)-fentanyl
3C-x
4C-x
DOx
HOT-x
MDxx
Mescaline (subst.)
TMAs
  • TMA
  • TMA-2
  • TMA-3
  • TMA-4
  • TMA-5
  • TMA-6
Others
Piperazines
Tryptamines
alpha-alkyltryptamines
x-DALT
x-DET
x-DiPT
x-DMT
x-DPT
Ibogaine-related
x-MET
x-MiPT
Others
Others
Dissociatives
(NMDAR
antagonists)
Arylcyclo‐
hexylamines
Ketamine-related
PCP-related
Others
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChR
antagonists)
Others
Cannabinoids
(CB1 agonists)
Natural
Synthetic
AM-x
CPx
HU-x
JWH-x
Misc. designer cannabinoids
D2agonists
GABAA
enhancers
Inhalants
(MixedMOA)
κORagonists
Oneirogens
Others
Lysergamides
Ergopeptines
Clavines
Other
ergolines
Related
compounds
Natural
sources


Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=1V-LSD&oldid=1280423211"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp